StonvexLoading…
StonvexStonvexStonvexCore line items from MRP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $194.93M | $600.46M | $410.96M | $231.70M |
Operating Income | $166.08M | $486.07M | $325.33M | $172.50M |
Net Income | $122.88M | $379.86M | $257.63M | $152.57M |
EPS (Diluted) | $0.74 | $2.44 | $1.70 | $1.07 |
Total Assets | $9.57B | $9.26B | $9.02B | $7.97B |
Total Liabilities | $3.72B | $3.40B | $3.17B | $2.10B |
Cash & Equivalents | $49.28M | $35.05M | $242.58M | $66.58M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 166.03M | 166.03M | 166.03M | 166.02M |